History of drug discovery: Early evaluation studies and lessons learnt from them

Progress in Respiratory Research

Volumn 40, Issue , 2011, Pages 2-9

  Ahmad, Zahoor ^a,b   Makaya, Nusrat Habib ^a   Grosset, Jacques ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052917910     PISSN: 14222140     EISSN: 16623932     Source Type: Book Series    
DOI: 10.1159/000324894     Document Type: Article

References (42)

1. Koch R: Die Aetiologie der Tuberkulose. Berl Klin Wochenschr 1882;19:221-230.
2. Avery OT, Dubos RJ: The specific action of a bacterial enzyme on pneumococci of type III. Science 1930;72B:151-152.
3. Domagk G: Ein Beitrag zur Chemotherapie der bakteriellen Infektionen. Dtsch Med Wochenschr 1935;61:250-253.
4. Domagk G, Behnisch R, Mietzsch F, Schmidt H: Über eine neue, gegen Tuberkelbazillen in vitro wirksame Verbindungsklasse. Naturwissenschaften 1946;33:1-4.
5. Dubos RJ: Bactericidal effect of an extract of a soil bacillus on Gram positive cocci. Proc Soc Exp Biol Med 1939;40:311-312.
6. Schatz A, Bugie E, Waksman S: Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. Proc Soc Exp Biol Med 1944;55:66-69.
7. Feldman WH, Hinshaw HC: Effects of streptomycin on experimental tuberculosis in guinea pigs. Proc Staff Meet Mayo Clin 1944;19:593-599.
8. Feldman WH, Hinshaw HC, Mann FC: Streptomycin in experimental tuberculosis. Am Rev Tuberc 1945;52:269-298.
9. Hinshaw HC, Feldman WH, Pfuetze KH: Treatment of tuberculosis with streptomycin: A summary of observations on one hundred cases, J Am Med Assoc 1946;132:778-782.
10. Medical Research Council investigation: Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948;ii:769-782.
11. Hinshaw HC, Feldman WH: Evaluation of chemotherapeutic agents in clinical tuberculosis: A suggested procedure. Am Rev Tuberc 1944;50:202-213.
12. Lehmann J: Para-aminosalicylic acid in the treatment of tuberculosis. Lancet 1946;247:15-16.
13. Bernheim F: The effect of salicylate on the oxygen uptake of the tubercle bacillus. Science 1940;92:204.
14. Medical Research Council Investigation: Treatment of pulmonary tuberculosis with streptomycin and para-amino-salicylic acid. Br Med J 1950;ii:1073-1085.
15. Bignall JR, Clegg JW, Crofton JW, Douglas Smith BJ, Holt D, Mitchison DA, Armitage P: Intermittent dosage in the treatment of pulmonary tuberculosis with streptomycin. Br Med J 1950;i:1224-1230.
16. Meyer H, Mally J: Über Hydrazinderivate der Pyridincarbonsä uren. Monatsh Chem verw Teile anderer Wiss 1912;23:393-414.
17. Huant E: Note sur l'action de très fortes doses d'amide nicotinique dans les lésions bacillaires. Gaz Hôp 1945;16:259-260.
18. Chorine V: Action de l'amide nicotinique sur les bacilles du genre Mycobacterium. C R Acad Sci 1945:220:150-151.
19. Editorial: New drugs for tuberculosis. N Engl J Med 1952;246:797-799.
20. Domagk G, Offe HA, Siefken W: Ein weiterer Beitrag zur experimentellen Chemotherapie der Tuberkulose (Neoteben). Dtsch Med Wochenschr 1952;77:573-578.
21. Benson WM, Stefko PL, Roe MD: Pharmacologic and toxicologic observations on hydrazine derivatives of isonicotinic acid (Rimifon, Marsilid). Am Rev Tuberc 1952;65:376-391.
22. Fox HH: The chemical approach to the control of tuberculosis. Science 1952;116:129-134.
23. Bernstein J, Lott WA, Steinberg BA, Yale HL: Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (Nydrazid) and related compounds. Am Rev Tuberc 1952;65:357-364.
24. Medical Research Council: The treatment of pulmonary tuberculosis with isoniazid. Br Med J 1952;ii:735-746.
25. Medical Research Council: Isoniazid in the treatment of pulmonary tuberculosis. Br Med J 1953;i:521-536.
26. Medical Research Council: Isoniazid in combination with streptomycin or with PAS in the treatment of pulmonary tuberculosis. Br Med J 1953;ii:1005-1014.
27. Medical Research Council: Various combinations of isoniazid with streptomycin or with PAS in the treatment of pulmonary tuberculosis. Br Med J 1955;i:435-445.
28. Medical Research Council-Tuberculosis Chemotherapy Trials Committee: Long-term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation. Tubercle 1962;43:201-267.
29. International Union against Tuberculosis: An international investigation of the efficacy of chemotherapy. Bull Int Union Tuberc 1964;34:79-191.
30. Fox W: Ambulatory chemotherapy in a developing country: Clinical and epidemiological studies. Adv Tuberc Res 1963;12:28-149.
31. Fox W: Methods of chemotherapy in developing countries. Bull Int Union Tuberc 1966;337:249-260.
32. Wilkerson RG, Shepherd RG, Thomas DP, Baughn C: Stereospecificity in a new type of antituberculosis agent. J Am Chem Soc 1961;83:2212-2213.
33. Sensi P: History of development of rifampin. Rev Infect Dis 1983;5:S402-S406.
34. Grumbach F, Rist N: Activité antituberculeuse expérimentale de la rifampicine, dérivée de la rifamycine SV. Rev Tuberc Pneum 1967;31:749-762.
35. British Thoracic and Tuberculosis Association: Short-course chemotherapy in pulmonary tuberculosis: A controlled trial. Lancet 1976;ii:1102-1104.
36. McKensie D, Malone L, Kushner S, Oleson JJ, Subbarow Y: Effect of nicotinamide acid amide on experimental tuberculosis of white mice. J Lab Clin Med 1948;33:1249-1253.
37. Kushner S, Dalalian H, Sanjurjo H, Bach JL Jr, Safir SR, Smith VK Jr, Williams JH: Experimental chemotherapy of tuberculosis. II. The synthesis of pyrazinamides and related compounds. J Am Chem Soc 1952;74:3617-3621.
38. Malone L, Schurr A, Lindh H, McKenzie D, Kiser JS, Williams JH: The effect of pyrazinamide (Aldinamide) on experimental tuberculosis in mice. Am Rev Tuberc 1952;65:511-518.
39. Yeager RL, Munroe WGC, Dessau FI: Pyrazinamide (Aldinamide) in the treatment of pulmonary tuberculosis. Am Rev Tuberc 1952;65:523-534.
40. East African/British Medical Research Councils: Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1972;i:1079-1085.
41. Hong Kong Tuberculosis Treatment Services/ British Medical Research Council: Controlled trial of 6-and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. Tubercle 1975;56:81-96.
42. British Thoracic Society: A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: Results during the 36 months after the end of chemotherapy and beyond. Br J Dis Chest 1984;78:330-336.